With CAGR of 10.4%, Anticonvulsants Market Size to Worth USD 3.20 Billion by 2028 The global anticonvulsants market size was USD 18.57 Billion in 2022 and is expected to register a revenue CAGR of 2.5% during the forecast period. Increasing prevalence of Epilepsy and other mental health disorders, rising Research and Development (R&D) activities by major companies, along with government measures in the form of funds and investments to support drug discovery and marketing are major factors driving revenue growth of the anticonvulsants market.Government authorities are taking various initiatives which are significantly contributing to the market revenue growth of anticonvulsants. For instance, on 27 June 2022, The Manitoba Government announced an annual operating funding commitment of more than USD 2.5 million to support the launch of the adult epilepsy surgery program and the growth of the pediatric program. Approximately 50 epilepsy procedures will be performed annually in Manitoba when the enlarged program is fully operational, including 20 adults and 30 pediatric cases. Surgery will be performed as part of the program at Manitoba hospital Health Sciences Centre (HSC) Winnipeg. Request a sample report of Anticonvulsants Market @ https://www.reportsanddata.com/download-free-sample/5918 Market Overview: People are increasingly susceptible to depression and mental health disorders, yet a growing awareness of health has prompted a recognition of the value of non-invasive and non-pharmaceutical therapies to address these conditions. According to the Centers for Disease Control and Prevention, over 50% of individuals in the U.S. have received a mental health diagnosis, with 1 in 5 people expected to experience a mental illness. Additionally, 1 in 5 children grapple with a debilitating mental disorder. Significant mental illnesses like bipolar disorder, major depression, or schizophrenia affect approximately 1 in 25 individuals. The World Health Organization reports that epilepsy impacts around 5 million people worldwide annually, with an estimated diagnosis rate of 49 per 100,000 in high-income countries and potentially reaching 139 per 100,000 in low- and medium-income countries. While the current diagnosis rates may appear low, the escalating awareness of health among individuals is leading to a gradual increase in the demand for anticonvulsants. Key Players covered in this report are • Johnson & Johnson Services, Inc. • Abbott • Novartis AG • Jazz Pharmaceuticals, Inc. • Teva Pharmaceutical Industries Ltd. • UCB S.A., Cephalon • Sunovion Pharmaceuticals Inc. • Eisai Co., Ltd. Based on Product Type market is segmented into: • Barbiturate • α-Amino-3-Hydroxy-5-Methyl-4-isoxazole Propionic acid (AMPA) • Carbamate Anticonvulsants Energy Management • Carbonic Anhydrase Inhibitor • Valproylamides (Amide Valproate) • Others Based on Application market is segmented into: • Epilepsy • Fibromyalgia • Neuropathic Pain • Anxiety • Migraine • Bipolar Disorder Read the full report @ https://www.reportsanddata.com/report-detail/anticonvulsants-market Based on Region market is segmented into: • North America • Europe • Asia-Pacific • South America • Middle East & Africa Major Points covered in this report are as below: • An analysis of Anticonvulsants industry development trends and marketing channels, as well as an assessment of the feasibility of new investment projects, is presented in the study. • In addition to providing key statistics on the industry, the report provides valuable guidance and direction for companies and individuals interested in this market through tables and figures. • In addition to developing policies and plans, this report analyzes manufacturing processes and cost structures. It also provides information about import/export demand, costs, prices, revenues, and gross margins. • This report provides information on the market status of Anticonvulsants manufacturers and provides valuable insight into the market for companies and individuals. Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/5918 We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa